Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133–146 (2023).
Addressing Long COVID: Advancing Research and Improving Patient Care, U.S. Senate, 2023–2024 sess (US Senate Committee on Health, Education, Labor & Pensions). https://www.help.senate.gov/hearings/addressing-long-covid-advancing-research-and-improvin.
Blitshteyn, S. et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PMR 14, 1270–1291 (2022).
Tabacof, L., Nicolau, E., Rivera, A. & Putrino, D. Post-COVID Conditions and Burden of Disease. Phys. Med. Rehabilitation Clin. North Am. 34, 499–511 (2023).
Wulf Hanson, S. et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA 328, 1604–1615 (2022).
Rahmati, M. et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences. J. Med. Virol. 95, e28852 (2023).
Fernandez-de-Las-Peñas, C. et al. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis. J. Infect. 88, 77–88 (2024).
Bowe, B., Xie, Y. & Al-Aly, Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 29, 2347–2357 (2023).
Hou, Y. et al. Global prevalence of long COVID, its subtypes and risk factors: an updated systematic review and meta-analysis. medRxiv. 2025.01.01.24319384 (2025).
Fleischer, N. L. et al. Long COVID and New Onset Disability Nearly 2 Years After Initial Infection. Am. J. Prev. Med 68, 1168–1172 (2025).
Bodey, R. et al. How long is long COVID? Evaluation of long-term health status in individuals discharged from a specialist community long COVID service. J Clin. Med. 13, https://doi.org/10.3390/jcm13195817 (2024).
National Academies of Sciences E, Medicine. A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences. The National Academies Press:186 (2024).
World Health Organization. World health statistics 2023: monitoring health for the SDGs, sustainable development goals. 2023. 19 May 2023. https://www.who.int/publications/i/item/9789240074323.
Ansah, J. P. & Chiu, C. T. Projecting the chronic disease burden among the adult population in the United States using a multi-state population model. Front Public Health 10, 1082183 (2022).
Bartsch, S. M. et al. The Current and Future Burden of Long COVID in the United States. J. Infect. Dis. 231, 1581–1590 (2025).
National Center for Health Statistics. U.S. Census Bureau, Household Pulse Survey, 2022–2024. Long COVID. Accessed 19 March 2026: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm.
Ford, N. D. et al. Long COVID and Significant Activity Limitation Among Adults, by Age – United States, June 1-13, 2022, to June 7-19, 2023. Morbidity Mortal. Wkly. Rep. 72, 866–870 (2023).
Cheng, A. L. et al. Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID: A compendium statement. PM R. 17, 684–708 (2025).
Appelman, B. et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat. Commun. 15, 17 (2024).
Smyth, N. J. & Blitshteyn, S. Language matters: what not to say to patients with Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome, and other complex chronic disorders. Int. J. Environ. Res. Public Health 22, https://doi.org/10.3390/ijerph22020275 (2025).
Hereth, B. et al. Long covid and disability: a brave new world. Br. Med. J. 378, e069868 (2022).
U.S. Food and Drug Administration. Virtual Public Meeting on Patient-Focused Drug Development for Long COVID (2023).
Ladyzhets, B. NIH documents show how $1.6 billion long Covid initiative has failed so far to meet its goals. STAT News. https://www.statnews.com/2024/05/31/long-covid-nih-recover-initiative-falls-short-on-causes-treatments/ (2023).
Nimgaonkar, A. et al. Exploring static and dynamic relationships between burden of disease and research funding in the United States. Health Res Policy Syst. 20, 60 (2022).
Gillum, L. A. et al. NIH disease funding levels and burden of disease. PLoS One 6, e16837 (2011).
Cohen, J. & van der Meulen Rodgers, Y. An intersectional analysis of long COVID prevalence. Int J. Equity Health 22, 261 (2023).
Ballreich, J. M., Gross, C. P., Powe, N. R. & Anderson, G. F. Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019. JAMA Netw. Open 4, e2034890 (2021).
Bonilla, H. et al. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. Review. Front. Immunol.14, https://doi.org/10.3389/fimmu.2023.1129459 (2023).
National Academies of Engineering Sciences and Math. Long COVID: Examining Long-Term Health Effects of COVID-19 and Implications for the Social Security Administration: Proceedings of a Workshop.https://doi.org/10.17226/26619 (2022).
Knoop, I. et al. Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies. Autonomic Neurosci. 244, 103052 (2023).
Choutka, J., Jansari, V., Hornig, M. & Iwasaki, A. Unexplained post-acute infection syndromes. Nat. Med 28, 911–923 (2022).
Astin, R. et al. Long COVID: mechanisms, risk factors and recovery. Exp. Physiol. 108, 12–27 (2023).
Mirin, A. A., Dimmock, M. E. & Jason, L. A. Updated ME/CFS prevalence estimates reflecting post-COVID increases and associated economic costs and funding implications. Fatigue.: Biomedicine, Health Behav. 10, 83–93 (2022).
Au, L., Capotescu, C., Eyal, G. & Finestone, G. Long covid and medical gaslighting: Dismissal, delayed diagnosis, and deferred treatment. SSM Qual. Res Health 2, 100167 (2022).
Mirin, A. A. Gender Disparity in the Funding of Diseases by the U.S. National Institutes of Health. J. Women’s Health (Larchmt.) 30, 956–963 (2021).
Household Pulse Survey, 2022–2024. Long COVID (2024).
Hanson, S. W. et al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv.https://doi.org/10.1101/2022.05.26.22275532 (2022).
Callard, F. & Perego, E. How and why patients made Long Covid. Soc Sci Med. 268, 113426 (2021).
Jindal, N. Senior Health Policy Advisor: Senate Commtitee on Health, Education, Labor & Pensions. 2024–2025.
Venkatesan, P. US Government cuts funding for long COVID research. Lancet Microbe 6, https://doi.org/10.1016/j.lanmic.2025.101166 (2025).
Smith, M. P. Estimating total morbidity burden of COVID-19: Relative importance of death and disability. J. Clin. Epidemiol. 142, 54–59 (2022).
Perlis, R. H. et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw. Open 5, e2238804 (2022).
Ma, Y. et al. Long-term consequences of COVID-19 at 6 months and above: a systematic review and meta-analysis. Int. J. Environ. Res. Public Health 19, https://doi.org/10.3390/ijerph19116865 (2022).
Ma, Y. et al. long-term consequences of asymptomatic SARS-CoV-2 Infection: a systematic review and meta-analysis. Int. J. Environ. Res. Public Health 20, https://doi.org/10.3390/ijerph20021613 (2023).
Vahratian, J., Lin, J. M. S., Bertolli, J. & Unger, E. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults: United States, 2021–2022. NCHS Data Brief. (2023).
Mirin, A. A., Dimmock, M. E. & Jason, L. A. Research update: The relation between ME/CFS disease burden and research funding in the USA. WORK: A J. Prev., Assess., Rehabilitation 66, 277–282 (2020).
Global Burden of Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. In: Supplement 1. Table S13. GBD 2019 sequelae hs, health state lay descriptions, and disability weights, editor. Lancet. 2020/10/19 ed2020. p. 1204–1222.
Cohrs, R. Long Covid research funding at NIH gets a nearly 50% boost. STAT. https://www.statnews.com/2024/02/15/long-covid-nih-funding-boost/ (2024).
Smith, K. Women’s health research lacks funding – these charts show how. Nature 617, 28–29 (2023).
Lund, E. M. & Ayers, K. B. Ever-changing but always constant: “Waves” of disability discrimination during the COVID-19 pandemic in the United States. Disabil. Health J. 15, 101374 (2022).
Reynolds, J. M. National Institutes of Health Designates Disabled People a Health Disparity Population. JAMA Health Forum 5, e241185–e241185 (2024).
Hall, J. P., Kurth, N. K., McCorkell, L. & Goddard, K. S. Long COVID Among People With Preexisting Disabilities. Am. J. Public Health 114, 1261–1264 (2024).
Sullivan, D. L., Goddard, K., Kurth, N. K. & Hall, J. P. I’m in Hell …”: Experiences of Unmet Health Care Needs Among People with Pre-Existing Disability and Long COVID. J. Health Care Poor Underserved 36, 572–589 (2025).
NIH designates people with disabilities as a population with health disparities. https://www.nih.gov/news-events/news-releases/nih-designates-people-disabilities-population-health-disparities. (2023).
Tanne, J. H. Covid-19: US studies show racial and ethnic disparities in long covid. Br. Med. J. 380, 535 (2023).
Cohen, J. & Rodgers, Y. V. M. Long COVID Prevalence, Disability, and Accommodations: Analysis Across Demographic Groups. J. Occup. Rehabil. 34, 335–349 (2024).
Millum, J. Should health research funding be proportional to the burden of disease? Politics, Philos. Econ. 22, 76–99 (2023).
